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The metabolism of benzene has been intensively studied, and its metabolic fate 
in the rabbit is well documented (Williams, 1959). Although partially excreted in the 
expired air, 30-4076 of ingested or inhaled benzene is hydroxylated and excreted as 
various phenolic products. These may appear in the urine in free or conjugated form. 
Recent studies of the enzymatic hydroxylating mechanism in liver indicate that 
this enzyme system is present in the microsomal fraction of liver cells (Mitoma et al., 
1956) and requires TPNH and oxygen for activity. It appears that the hydroxylating 
enzyme system is also responsible for a number of other metabolic processes, including 
N-demethylation. A report by Roth and Bukovsky (1961) indicates that the N-de- 
methylating enzyme activity of rabbit liver drops almost to zero after 24 hours of 
fasting. If hydroxylating activity is also depressed to this extent by fasting, then 
the immediate nutritional state of animals during toxicity testing procedures may 
play a most important role in determining the degree of toxicity which becomes 
apparent during the test period. One can foresee that aromatic compounds which are 
hydroxylated to produce metabolites more toxic than the parent compound would 
have an apparent decreased toxicity in animals unable to hydroxylate the ingested 
compound. Conversely, compounds hydroxylated to yield metabolites which are less 
toxic than the parent compound would appear more toxic in animals with impaired 
hydroxylating mechanisms. Thus fasting, or the presence of chemical compounds that 
inhibit hydroxylation, may alter the apparent toxicity of ingested chemicals. p-Diethyl- 
aminoethyldiphenylpropylacetate hydrochloride” (P-DDH) is a compound which has 
been shown to inhibit the hydroxylating enzyme system (Cook et al., 1954). 
The present study was designed to determine the effect of fasting and the injection 
of P-DDH on the acute oral toxicity and metabolic fate of benzene. 
METHODS 
Acute oral toxicity. Male Sprague-Dawley rats of the Holtzman strain, weighing 
200-250 g, were utilized in the acute toxicity tests. Oral toxicity was determined by 
feeding geometrically graded dosages of reagent-grade benzene3 to groups of 10 rats 
at each dosage. The LDsO and 957% confidence level were calculated by the method 
1 This study was supported, in part, by U.S. Public Health Service research grant no. MH- 
03692 from the Institute of Mental Health, National Institutes of Health. 
2 SKF 525-A, Smith, Kline & French Laboratories, Philadelphia, Pennsylvania. 
3 Mallinckrodt Chemical Works, St. Louis, Missouri. 
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of Weil (1952). The LD:,,,‘s of benzene were determined for rats on the following 
treatments: (a) nonfasted; (b) fasted for 24 hours; (c) nonfasted, but injected with 
80 mg/kg of /3-DDH intraperitoneally 45 minutes prior to oral administration of 
benzene; and (d) fasted for 24 hours and injected with 80 mg/kg of P-DDH 45 
minutes prior to oral administration of benzene. 
Metabolism. Male rats similar to those used in the acute toxicity tests, weighing 
200-250 g, were maintained on a normal test diet4 and in individual metabolism cages 
designed for the collection of urine uncontaminated by food or feces. Complete urine 
samples were collected by a gentle squeezing of each animal at the end of the ,X-hour 
period. The samples were diluted to 20 ml with water, mixed, filtered, and utilized 
for the determination of phenols and glucuronides. The Dische (1947) method was 
used for the determination of glucuronides. Standard solutions were prepared from 
recrystallized n-glucuronic acid.” Free and total phenols were measured with the 
Folin-Ciocalteu (1927) reagent standardized against pure phenol. Conjugated phenols 
were calculated as the difference between total and free phenols. Individual 24-hour 
urine samples were collected daily on all rats for a control period of 4 days, prior 
to the treatments described below. 
One group of 8 rats was injected intraperitoneally with 88 mg of benzene, and 
24-hour urine samples were collected daily for the next 4 days. Another group of 
8 rats was fasted for 48 hours. Four animals of this group received 88 mg of benzene 
intraperitoneally after the first 24 hours; the others were maintained as controls. 
The 24-hour period of urine collection commenced with the benzene injection. The 
third group of 8 animals was injected intraperitoneally with 80 mg/kg of @-DDH; 
45 minutes later, 4 of these animals received a single 88-mg intraperitoneal dose of 
benzene. Twenty-four-hour urine samples were collected over the subsequent 4 days. 
Acute Oral Toxicity 
RESULTS 
The LDbO of benzene for nonfasted rats was found to be 0.93 (0.71-1.23) g of 
benzene per kilogram. In 24-hour fasted rats, the LDjo was 0.81 (0.69-0.95) g/kg. 
The LDAo in fi-DDH-treated rats was 1.04 (0.69-1.57) g/kg; and in 24-hour fasted 
P-DDH-treated rats, 0.76 (0.51-1.01) g/kg. At high dosages of benzene ( 1.87 g/kg) 
the animals developed tremors and tonic-clonic convulsions, and many died within 20 
minutes. A single dose of 88 mg produced slight central nervous system depression, 
but no deaths. Hence, this amount was used in subsequent metabolic studies. 
Metabolism 
In Fig. 1 are shown the daily excretions of glucuronide and free and total phenol. 
Normal free phenol excretion in any one group of rats (days l-4) varies by not 
more than 2 mg in 24 hours. The injection of benzene on day 4 into nonfasted or 
24-hour fasted rats resulted in marked increases (P < 0.001) in free phenol excretion 
during the subsequent 24hour period (Fig. 1B). Within 48 hours, these values are 
again within the normal range. Fasting alone results in a slight decrease (p < 0.001) 
in free phenol excretion. The injection of B-DDH prior to benzene injection (Fig. IE) 
4 Nutritional Biochemicals Corporation, Chagrin Falls, Ohio. 
5 Sigma Chemical Company, St. Louis, Missouri. 
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results in a marked depression (P < 0.001) of the expected free phenol excretion, 
but not a complete block. @DDH does not markedly alter free phenol excretion in 
control rats. 
The data with respect to total phenol excretion are more variable from day to day 
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FIG. 1. Daily excretion of metabolites in nonfasted, fasted, and fi-DDH-treated rats. The first 
4 days are control days. The vertical bars represent the standard error of the mean excretion for 
day 5. Where the administration of benzene is indicated, the animals received an intraperitoneal 
injection of 88 mg of benzene at the end of day 4 as indicated by the arrow. P-DDH, 80 mg/kg 
intraperitoneally, was also administered at this time (45 minutes prior to the dose of benzene 
when the two were given to the same animal). 
are markedly elevated (P < 0.001) above control levels (Fig. 1A). This represents 
an increase of approximately 25 mg of conjugated phenol per 24 hours, including 
both glucuronide and other conjugated phenols. l3-DDH injection prolongs total 
phenol excretion over a period of several days following benzene injection (Fig. 1D). 
In benzene-injected, fasted rats, total phenol excretion is nearly double that of ben- 
zene-injected, nonfasted rats if one considers the low total phenol excretion in fasted 
animals (Fig. 1A). 
The data with respect to glucuronide excretion are quite clear (Fig. lC,F). The 
injection of benzene results in a small increase in glucuronide excretion during the 
subsequent 24-hour period (P < 0.001). Fasted animals show a slight reduction in 
glucuronide excretion (P < O.OOl), but fasted animals injected with benzene exhibit 
an increase in glucuronide excretion which is approximately three times the increase 
noted in nonfasted benzene-injected rats. The administration of P-DDH inhibits the 
excretion of benzene as the glucuronide (Fig. 1F). 
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Total excretion of injected benzene is shown in Table 1. In this table, excretion of 
the various metabolites is expressed as milligrams of injected benzene and is calcu- 
lated over the 24-hour period following the injection of benzene, except in the case 
of total phenol excretion after p-DDH treatment, where a significant excretion during 
the second 24-hour period is included in the total. In nonfasted animals injected with 
TABLE 1 
MEAN URINARY EXCRETION OF BENZENE METAROLITES IN NONFASTED, FASTED, AND fi-DDH-TREATED 





Fasted 24 hours 20 
(18-21) 
P-DDH-treated 0 
(80 w/k, i.p.1 (0-l) 
a Each group contained 8 animals. 
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b All values are expressed as milligrams of benzene. The range is in parentheses. 
c As percentage of the dose. 
88 mg of benzene, only a few milligrams are excreted as free phenol and as glucu- 
ronides. The major metabolites are conjugated phenols other than glucuronides. These 
conjugated phenols account for 14-1970 of the 88 mg dose of benzene given to non- 
fasted rats. Total excretion of metabolites accounts for approximately 36% of the 
dose when 88 mg of benzene is injected into 24-hour fasted rats. P-DDH prevents 
the excretion of benzene as the glucuronide, and only a trace of free phenols and 
approximately 12 mg of benzene as conjugated phenols are excreted over the subse- 
quent 48-hour period. 
DISCUSSION 
The excretory pattern of benzene in the normal rat is consistent with that reported 
for the rabbit (Williams, 1959). The major metabolites in the rat are conjugated 
phenols, other than glucuronides. In the rabbit, these conjugated phenols are pri- 
marily ethereal sulfates. Rats fasted for 24 hours prior to the injection of benzene 
present an entirely different metabolic picture. There is no increase in conjugated 
phenol excretion other than that due to a marked increase in glucuronide excretion. 
This is apparently due to a lack of dietary sulfate and the consequent necessity of 
metabolizing benzene by alternate pathways. Free phenol excretion is also increased 
in fasted, benzene-treated rats. Such drastic alterations in metabolic pattern could 
well result in marked differences in acute toxicity under conditions where metabolic 
products may differ from the ingested compound in their toxic effects. In the present 
study, the LDSO’s of benzene were not markedly different in control, fasted, fl-DDH- 
injected, and fasted rats injected with P-DDH in spite of the metabolic differences 
presented. The prior injection of P-DDH into rats receiving an intraperitoneal in- 
jection of 88 mg of benzene markedly depressed the conversion of benzene to glucu- 
ronides and free phenols. Although metabolic patterns were altered in these studies, 
the total excretory rate of benzene by these routes was perhaps not altered sufficiently 
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to affect acute toxicity. Since benzene is also excreted in the expired air, this alternate 
pathway of excretion may compensate for variations in metabolic fate of volatile 
substances. 
SUMMARY 
The metabolic fate of benzene is markedly altered in rats fasted 24 hours prior to administration 
of the compound. In the nonfasted rat, the major metabolites are conjugated phenols other than 
glucuronides, while in the fasted rat the major excretory pathway is glucuronide conjugation. In 
rats treated with fi-diethylaminoethyldiphenylpropylacetate hydrochloride all excretory pathways 
requiring hydroxylation are depressed. Thus the nutritional state of the animal, as well as prior 
administration of biologically active compounds, may markedly alter the metabolic fate of 
ingested compounds and should be considered during metabolic studies or toxicity testing pro- 
cedures. 
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